News
KalVista Pharmaceuticals receives UK MKRA marketing authorization for sebetralstat to treat hereditary angioedema attacks: Cambridge, Massachusetts Friday, July 18, 2025, 12:00 Hr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback